Structural basis for ligand reception by anaplastic lymphoma kinase.

Nature 2022
Open on PubMed

The proto-oncogene ALK encodes anaplastic lymphoma kinase, a receptor tyrosine kinase that is expressed primarily in the developing nervous system. After development, ALK activity is associated with learning and memory<sup>1</sup> and controls energy expenditure, and inhibition of ALK can prevent diet-induced obesity<sup>2</sup>. Aberrant ALK signalling causes numerous cancers<sup>3</sup>. In particular, full-length ALK is an important driver in paediatric neuroblastoma<sup>4,5</sup>, in which it is either mutated<sup>6</sup> or activated by ligand<sup>7</sup>. Here we report crystal structures of the extracellular glycine-rich domain (GRD) of ALK, which regulates receptor activity by binding to activating peptides<sup>8,9</sup>. Fusing the ALK GRD to its ligand enabled us to capture a dimeric receptor complex that reveals how ALK responds to its regulatory ligands. We show that repetitive glycines in the GRD form rigid helices that separate the major ligand-binding site from a distal polyglycine extension loop (PXL) that mediates ALK dimerization. The PXL of one receptor acts as a sensor for the complex by interacting with a ligand-bound second receptor. ALK activation can be abolished through PXL mutation or with PXL-targeting antibodies. Together, these results explain how ALK uses its atypical architecture for its regulation, and suggest new therapeutic opportunities for ALK-expressing cancers such as paediatric neuroblastoma.